B-cell Lymphoma Clinical Trials in Shanghai, Shanghai Municipality
13 recruitingShanghai, Shanghai Municipality, China
Showing 1–13 of 13 trials
Recruiting
Early Phase 1
A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
Relapsed/Refractory Large B-Cell Lymphoma
Shenzhen Fosun Kairos Biotechnology Co., Ltd.12 enrolled6 locationsNCT07606937
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mantle Cell LymphomaB-cell Lymphoma
BeOne Medicines300 enrolled152 locationsNCT06742996
Recruiting
Phase 3
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Hutchmed240 enrolled41 locationsNCT07409428
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study
Large B-cell Lymphoma
Fudan University80 enrolled1 locationNCT07236203
Recruiting
Phase 1Phase 2
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
B-cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine50 enrolled1 locationNCT06987916
Recruiting
Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
B-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.80 enrolled30 locationsNCT06566586
Recruiting
Phase 4
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital8 enrolled1 locationNCT05806580
Recruiting
Phase 2
The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy
Extranodal Marginal Zone B-cell Lymphoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University50 enrolled1 locationNCT06503276
Recruiting
Phase 1
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Advanced Solid TumorsRelapsed/Refractory B-cell Lymphoma
InSilico Medicine Hong Kong Limited60 enrolled2 locationsNCT06445517
Recruiting
Phase 1
CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
Acute Lymphoblastic Leukemia, in RelapseB-cell Lymphoma RecurrentB-cell Lymphoma Refractory+1 more
Rong Tao48 enrolled2 locationsNCT06445803
Recruiting
Phase 2
Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL
Diffuse Large B-cell Lymphoma RecurrentDiffuse Large B Cell Lymphoma Refractory
RenJi Hospital20 enrolled1 locationNCT06033820
Recruiting
Cell Free DNA in Mature B-cell Lymphoma
Mature B-Cell Lymphoma
Ruijin Hospital320 enrolled1 locationNCT04088422